文献速递慢病管理预防保健、筛查与疫苗

基层医生处方动态血糖监测的障碍与需求

Clinician-Reported Barriers and Needs for Implementation of Continuous Glucose Monitoring.
PubMed 文献 · J Am Board Fam Med · 2024-01-01

本研究通过半结构化访谈55名来自21个州的全科医生,了解其在基层处方动态血糖监测(CGM)的障碍与所需资源。医生认可CGM对糖尿病患者的益处,但主要障碍为保险覆盖不足和時間限制,并指出需要教育、支持人员及电子健康记录兼容等资源。

要点

  • 基层医生认可CGM对不同程度自我管理糖尿病患者的益处。
  • 处方CGM的主要障碍是患者保险覆盖不足和时间限制。
  • 医生希望获得CGM教育、支持人员及电子健康记录兼容性支持。

核心结论

  • 基层医生处方CGM面临多重挑战,但有意愿学习以提供给患者。
  • 需要加强医生CGM技术教育并扩大保险覆盖范围。

研究设计与样本

  • 定性研究,采用半结构化访谈,通过实践研究网络招募21个州的55名基层医生。
  • 使用快速定性分析总结访谈主题。

主要发现

  • 参与者描述了CGM对不同自我管理水平和参与度糖尿病患者的益处。
  • 处方的主要障碍包括患者CGM费用缺乏保险覆盖和时间限制。
  • 参与者指出促进CGM处方所需资源包括医生教育、支持人员和电子健康记录兼容性。

关键数值与推荐

  • CGM是美国糖尿病协会医疗标准的一部分,与1型和2型糖尿病患者临床、行为和心理社会健康结局改善相关。
  • 50%的1型糖尿病成人和90%的2型糖尿病患者在基层接受糖尿病照护。

临床怎么用

  • 基层医生应了解CGM对糖尿病管理的益处,并评估患者保险覆盖情况。
  • 可寻求医生教育、支持人员协助及电子健康记录兼容性资源以促进CGM处方。

局限性

  • 定性研究设计可能限制结果普遍性,样本来自实践研究网络。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Continuous glucose monitoring (CGM) for patients with type 1 and type 2 diabetes is associated with improved clinical, behavioral, and psychosocial patient health outcomes and is part of the American Diabetes Association's Standards of Medical Care. CGM prescription often takes place in endocrinology practices, yet 50% of adults with type 1 diabetes and 90% of all people with type 2 diabetes receive their diabetes care in primary care settings. This study examined primary care clinicians' perceptions of barriers and resources needed to support CGM use in primary care. METHODS: This qualitative study used semistructured interviews with primary care clinicians to understand barriers to CGM and resources needed to prescribe. Participants were recruited through practice-based research networks. Rapid qualitative analysis was used to summarize themes from interview findings. RESULTS: We conducted interviews with 55 primary care clinicians across 21 states. Participants described CGM benefits for patients with varying levels of diabetes self-management and engagement. Major barriers to prescribing included lack of insurance coverage for CGM costs to patients, and time constraints. Participants identified resources needed to foster CGM prescribing, for example, clinician education, support staff, and EHR compatibility. CONCLUSION: Primary care clinicians face several challenges to prescribing CGM, but they are interested in learning more to help them offer it to their patients. This study reinforces the ongoing need for improved clinician education on CGM technology and continued expansion of insurance coverage for people with both type 1 and type 2 diabetes.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Hall T, Warman MK, Oser T, et al. Clinician-Reported Barriers and Needs for Implementation of Continuous Glucose Monitoring. J Am Board Fam Med. 2024. PMID: 39455273. doi:10.3122/jabfm.2024.240049R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。